Sphincter of Oddi dysfunction: Diagnosis and treatment

Research output: Contribution to journalArticle

62 Citations (Scopus)

Abstract

In summary, our knowledge of sphincter of Oddi dysfunction and manometric techniques to assist in this diagnosis are evolving. Successful endoscopic SOM requires good general ERCP skills and careful attention to the main details listed above. If SOD is suspected in a Type III or mild to moderate pain level Type II patient, medical therapy should generally be tried. If medical therapy fails or is bypassed, ERCP and manometric evaluation are recommended. The role of lessinvasive studies remains uncertain due to undefined sensitivity and specificity. Sphincter ablation is generally warranted in symptomatic Type I patients and Type II and III patients with abnormal manometry. The symptom relief rate varies from 55 to 95%, depending on the patient presentation and selection. Initial non-responders require thorough pancreatic sphincter and pancreatic parenchymal evaluation. SOD patients have relatively high complication rates after invasive studies or therapy. Thorough review of the risk: benefit ratio with individual patients is mandatory.

Original languageEnglish
Pages (from-to)382-400
Number of pages19
JournalJournal of the Pancreas
Volume2
Issue number6
StatePublished - Nov 2001

Fingerprint

Sphincter of Oddi Dysfunction
Endoscopic Retrograde Cholangiopancreatography
Therapeutics
Manometry
Patient Selection
Odds Ratio
Sensitivity and Specificity
Pain

Keywords

  • Cholangiopancreatography, endoscopy retrograde
  • Manometry
  • Oddi's sphincter
  • Pancreatitis, acute necrotizing
  • Sphincterotomy, endoscopic

ASJC Scopus subject areas

  • Endocrinology
  • Gastroenterology

Cite this

Sphincter of Oddi dysfunction : Diagnosis and treatment. / Sherman, Stuart; Lehman, Glen.

In: Journal of the Pancreas, Vol. 2, No. 6, 11.2001, p. 382-400.

Research output: Contribution to journalArticle

@article{f4ef1994b1fc4d6286b3d09ce86cfebb,
title = "Sphincter of Oddi dysfunction: Diagnosis and treatment",
abstract = "In summary, our knowledge of sphincter of Oddi dysfunction and manometric techniques to assist in this diagnosis are evolving. Successful endoscopic SOM requires good general ERCP skills and careful attention to the main details listed above. If SOD is suspected in a Type III or mild to moderate pain level Type II patient, medical therapy should generally be tried. If medical therapy fails or is bypassed, ERCP and manometric evaluation are recommended. The role of lessinvasive studies remains uncertain due to undefined sensitivity and specificity. Sphincter ablation is generally warranted in symptomatic Type I patients and Type II and III patients with abnormal manometry. The symptom relief rate varies from 55 to 95{\%}, depending on the patient presentation and selection. Initial non-responders require thorough pancreatic sphincter and pancreatic parenchymal evaluation. SOD patients have relatively high complication rates after invasive studies or therapy. Thorough review of the risk: benefit ratio with individual patients is mandatory.",
keywords = "Cholangiopancreatography, endoscopy retrograde, Manometry, Oddi's sphincter, Pancreatitis, acute necrotizing, Sphincterotomy, endoscopic",
author = "Stuart Sherman and Glen Lehman",
year = "2001",
month = "11",
language = "English",
volume = "2",
pages = "382--400",
journal = "Journal of the Pancreas",
issn = "1590-8577",
publisher = "E.S. Burioni Ricerche Bibliografiche",
number = "6",

}

TY - JOUR

T1 - Sphincter of Oddi dysfunction

T2 - Diagnosis and treatment

AU - Sherman, Stuart

AU - Lehman, Glen

PY - 2001/11

Y1 - 2001/11

N2 - In summary, our knowledge of sphincter of Oddi dysfunction and manometric techniques to assist in this diagnosis are evolving. Successful endoscopic SOM requires good general ERCP skills and careful attention to the main details listed above. If SOD is suspected in a Type III or mild to moderate pain level Type II patient, medical therapy should generally be tried. If medical therapy fails or is bypassed, ERCP and manometric evaluation are recommended. The role of lessinvasive studies remains uncertain due to undefined sensitivity and specificity. Sphincter ablation is generally warranted in symptomatic Type I patients and Type II and III patients with abnormal manometry. The symptom relief rate varies from 55 to 95%, depending on the patient presentation and selection. Initial non-responders require thorough pancreatic sphincter and pancreatic parenchymal evaluation. SOD patients have relatively high complication rates after invasive studies or therapy. Thorough review of the risk: benefit ratio with individual patients is mandatory.

AB - In summary, our knowledge of sphincter of Oddi dysfunction and manometric techniques to assist in this diagnosis are evolving. Successful endoscopic SOM requires good general ERCP skills and careful attention to the main details listed above. If SOD is suspected in a Type III or mild to moderate pain level Type II patient, medical therapy should generally be tried. If medical therapy fails or is bypassed, ERCP and manometric evaluation are recommended. The role of lessinvasive studies remains uncertain due to undefined sensitivity and specificity. Sphincter ablation is generally warranted in symptomatic Type I patients and Type II and III patients with abnormal manometry. The symptom relief rate varies from 55 to 95%, depending on the patient presentation and selection. Initial non-responders require thorough pancreatic sphincter and pancreatic parenchymal evaluation. SOD patients have relatively high complication rates after invasive studies or therapy. Thorough review of the risk: benefit ratio with individual patients is mandatory.

KW - Cholangiopancreatography, endoscopy retrograde

KW - Manometry

KW - Oddi's sphincter

KW - Pancreatitis, acute necrotizing

KW - Sphincterotomy, endoscopic

UR - http://www.scopus.com/inward/record.url?scp=0035525529&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035525529&partnerID=8YFLogxK

M3 - Article

C2 - 11880698

AN - SCOPUS:0035525529

VL - 2

SP - 382

EP - 400

JO - Journal of the Pancreas

JF - Journal of the Pancreas

SN - 1590-8577

IS - 6

ER -